Month: 2026-07 Key features delivered: - Quantitative C-Reactive Protein lab test added to ozone-hsc, expanding diagnostic capabilities for inflammation assessment. Commit: 2af4676eee8856fa9ebe06b9d9537504d14c4eb2 (HSC-574: Add Quantitative C-Reactive Protein lab test (#221)). - Ocufloxacin Gouttes dosage form concept updated to reflect new specifications, ensuring accurate representation in the system. Commit: e3b8c745647f3ed17d93927ee4273dcae9e39226 (HSC-547: Update concept dosage form for Ocufloxacin Gouttes (#222)). Major bugs fixed: - None reported for this repository in July 2026. Overall impact and accomplishments: - Expanded diagnostic breadth and data fidelity, enabling better decision support and more reliable data flows for lab tests and dosage forms. Alignment with product roadmap and regulatory expectations. Technologies/skills demonstrated: - Feature development and commit traceability, domain modeling for lab tests and dosage forms, and disciplined version-control practices.

June 2026: Delivered cross-system medication management integration for O3 and enhanced product handling in Odoo, with new configuration files, data models, and clinician-facing forms. Completed release documentation for the 2.4.0 cycle and prepared the roadmap for 2.5.0-SNAPSHOT, enabling smoother deployments and future development.

May 2026: Key wins include a data integrity fix removing duplicate Hydrocelectomie concepts; release management for 2.3.3 (notes, version bumps, pom updates, translation refresh); and new data collection forms (Triage and Observations) with decimal flow rates and bilingual translations. These changes sharpen data quality, accelerate deployments, and enhance clinician data capture across the ozone-hsc project.

April 2026 monthly summary for mekomsolutions/ozone-hsc: Implemented end-to-end enhancements to streamline clinical workflows, strengthen data integrity, and improve release readiness. Key features include Ozone Health System (O3) procedure orders and Odoo integration to optimize healthcare services management and inventory; data model cleanup/enhancement for Herniorraphie ombilicale etranglee to remove duplicates and improve integrity; glycémie terminology clarified by renaming 'Glycémie' to 'Glycémie test' for clearer UX and analytics; release/versioning updates for 2.3.2 and 2.4.0-SNAPSHOT, plus documentation of OpenMRS frontend build process adjustments. These changes boost operational efficiency, data quality, and deployment velocity across the platform.

March 2026 performance summary for mekomsolutions/ozone-hsc focused on delivering business value through frontend modularity improvements and streamlined release management. The month centered on enhancing frontend configuration, consolidating versioning, and documenting releases to support maintainability and faster time-to-market.

February 2026 monthly summary focusing on key accomplishments, business value, and technical achievements for mekomsolutions projects ozone-hsc and ozone-haiti. The period concentrated on feature delivery, interoperability enhancements, multilingual usability, and release readiness to support upcoming deployments. Key work spanned cross-system integrations, UI/translation improvements, and release governance.

January 2026 (2026-01) monthly summary for mekomsolutions/ozone-hsc. Focused on expanding procedure management, enriching user-facing widgets, and tightening localization. Key features delivered include two new procedure orders (BAAF and Biopsy) with blood requisition integration, and enhancements to the Lifestyle Widget to display new lifestyle choices. Major bug fix addressed translation consistency in the Emergency form (English and French, including Tetanus terminology). Overall impact includes streamlined procedure management, improved health data representation, and stronger localization accuracy, boosting user efficiency and business value. Technologies/skills demonstrated include full-stack development, API integration for procedure orders and blood requisition, UI/UX widget enhancements, and localization/internationalization.

December 2025 monthly summary for two repositories: ozone-hsc and ozone-haiti. Focused on feature delivery in clinical forms, data integrity improvements, and multilingual support. No major bug fixes documented in this period.

October 2025 - Provided key platform improvements in the ozone-hsc repository focused on RBAC enhancements, data model enrichment, and release governance. No major bugs fixed this period; the work prioritized delivering business value through feature expansion and improved lifecycle documentation. Specific outcomes include expanded IPD and Nurse IPD privileges, richer encounter concept data schema, and comprehensive release notes and versioning from 2.2.0 to 2.3.0-SNAPSHOT. These changes enhance clinical workflow accuracy, data quality, and development transparency, enabling faster IPD onboarding, standardized concept management, and clearer customer communications.

September 2025 focused on refining clinician access to clinical forms in ozone-hsc. Delivered Doctor Role Privilege Expansion for Clinical Forms Management, enabling doctors to view and edit a comprehensive set of clinical forms to improve data governance and care delivery. Implemented under commit e16ccc6ea325b75502b41ccef8f452c9d28f0fed (HSC-526). No major bugs fixed this month. Impact: faster clinical data workflows, improved data accuracy and governance, and alignment with security/compliance requirements. Skills demonstrated: RBAC/permissions design, secure data access patterns, code traceability, and collaboration with issue tracking.

August 2025 monthly summary highlighting targeted stabilization work in the ozone-hsc project. A rollback was implemented to revert to stable package versions across Ozone Haiti, Ozone, and Ozone Pro to restore reliability after destabilizing updates. The change was driven by the need to maintain production stability and minimize support impact while we plan longer-term stabilization.

July 2025 focused on strengthening access control, documenting and stabilizing releases, and establishing ongoing development versioning across two projects. Key outcomes include tightening RBAC for patient identifiers, shipping and documenting a 2.1.0 release with a new privilege, and setting up the 2.2.0-SNAPSHOT development line. In parallel, release documentation and versioning for the Haiti project were prepared for 1.1.0 with an eye toward 1.2.0-SNAPSHOT. These efforts improve data governance, release readiness, and cross-project consistency with clear business value in security, maintainability, and faster iteration.

May 2025 monthly summary focused on targeted repo hygiene and maintainability improvements across two repositories. Delivered a feature cleanup to simplify the ozone-haiti project structure and a maintenance fix to prevent unintended processing in ozone-hsc. The work reduces technical debt, improves data integrity, and supports faster onboarding and reliable builds.

April 2025 monthly work summary: Delivered cross-repo configuration expansions and a dependency upgrade across ozone-hsc and ozone-haiti, enabling broader service-point configurability and keeping dependencies current. In ozone-hsc, expanded healthcare service point login locations (Administration, Archives, Cashier, Pharmacy) and visit types (Laboratory, Radiology), along with a configuration update to correct the Administration location UUID, improving mapping correctness and patient flow routing. In ozone-haiti, upgraded esm-patient-billing-status-app to version 1.0.1-pre.27 as part of HSC-450; no code changes beyond the version bump, maintaining compatibility and ensuring billing-status logic stays aligned with the latest specifications. This work enhances provider onboarding flexibility, reduces misconfiguration risk, and supports timely, accurate billing status checks. Key technical themes included configuration management, dependency management, and multi-repo coordination, with clear traceability to tickets and commits.

Concise March 2025 monthly summary for two repositories (mekomsolutions/ozone-haiti and mekomsolutions/ozone-hsc). Focused on delivering business value through stable releases, clear release notes, and disciplined versioning, with strong emphasis on release engineering and repo hygiene.

February 2025 performance summary for mekomsolutions: Delivered localization readiness for French across ozone-haiti, refreshed branding and community onboarding messaging for ozone-hsc, and implemented enhanced role-based access controls to support Registration Clerk and Nurse Limited workflows. No major bugs fixed this month. These changes reduce localization friction, improve onboarding clarity, and strengthen workflow security, laying groundwork for broader localization rollout and healthcare-specific access governance.

During January 2025, delivered user-facing UI enhancements for accurate anthropometric data entry, formalized licensing terms, and refreshed branding/documentation to align with project evolution. These changes improved data clarity, ensured license compliance, and strengthened the project's external presentation across two repositories.

Monthly summary for 2024-12 focused on strengthening test reliability and CI stability by upgrading Playwright to 1.49.0 across four OpenMRS ESM repositories. Delivered four dependency upgrades (patient-chart, form-builder, stock-management, core), updating Dockerfiles and yarn.lock to reflect the new Playwright version. This work reduces flaky tests, shortens feedback cycles, and improves overall quality assurance across the suite.

Month: 2024-11 Key features delivered: - Playwright Testing Framework Upgrade to Latest Stable Version in openmrs/openmrs-esm-core: Updated Dockerfile to use the newer Playwright image and refreshed yarn.lock to reflect the new Playwright npm package; commit 7eac2105c10f2753775be77283213939aeed1c9f (#1199). The upgrade improves end-to-end testing reliability and aligns with current best practices. Major bugs fixed: - None identified or committed this month; no major bug fixes in this period. Overall impact and accomplishments: - Improved end-to-end test reliability and stability, reducing flaky tests and aligning CI with current best practices. - Enables faster iteration and more dependable release readiness by maintaining up-to-date testing tooling. Technologies/skills demonstrated: - Playwright, Dockerfile maintenance, Yarn/NPM version management, release & CI workflow maintenance, change impact assessment, and documentation of changes.

October 2024 — Focused on stabilizing end-to-end testing for the openmrs/openmrs-esm-patient-chart module. Delivered the End-to-End Testing Environment Upgrade: Playwright 1.48.2 by updating the Dockerfile base image and yarn.lock, ensuring E2E tests run on the latest stable Playwright. No critical bugs fixed this month; primary impact came from improvements in test reliability and CI readiness to accelerate safe releases. Commit: 9ed992fd2c93f4886fc79f06865007fedaf5e7a6 ("(chore) Bump Playwright (#2083)").